Acute renal failure resulting from intravenous immunoglobulin therapy.
about
Myasthenia gravisIntravenous immunoglobulin for Guillain-Barré syndromeIntravenous immunoglobulin for Guillain-Barré syndromeIntravenous immunoglobulin for Guillain-Barré syndromeIntravenous immunoglobulin for Guillain-Barré syndromeIntravenous immunoglobulin for Guillain-Barré syndromeHematologic complications of anti-CMV therapy in solid organ transplant recipients.Adverse postoperative outcomes in surgical patients with immune thrombocytopenia.Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.Acute renal failure after large doses of intravenous immune globulin.Natural history and treatment effects in Guillain-Barré syndrome: a multicentre studyCurrent concepts and controversy in chronic inflammatory demyelinating polyneuropathy.Intravenous immune globulins: an update for clinicians.Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation.Drug-induced nephropathy: an update.Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.Current treatments of chronic immune-mediated demyelinating polyneuropathies.Sugar-free, glycine-stabilized intravenous immunoglobulin prevents skin but not renal disease in the MRL/lpr mouse model of systemic lupus.Diabetic Lumbosacral Polyradiculoneuropathies.Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part II.Intravenous immunoglobulin in the Guillain-Barré syndrome. Products with low IgA content may be used in patients with total IgA deficiency.Acute renal failure complicating high-dose intravenous immunoglobulin therapy for acquired haemophilia.Acute renal failure in acquired haemophilia following the use of high dose intravenous immunoglobulin.Autoimmune Myasthenia Gravis: Recommendations for Treatment and Immunologic Modulation.Failure of intravenous immunoglobulin to arrest progression of multiple sclerosis: a clinical and MRI based study.Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis
P2860
Q21202960-4D80740D-9D61-45BD-B83D-A9831ADA16FAQ24193522-D44C3628-6DBC-4838-BA76-C98E44DA4244Q24202100-99C3E922-8CAC-4B00-8D7F-AA3A7DDEC637Q24234992-656C3E60-64FB-4537-8645-DEDCFC3AC86CQ24244575-BB575FA1-E9A6-473F-9CE7-4D9EA0D2958BQ24247429-C8018966-DFBA-45CC-9033-C63450A0183BQ33383116-5501B45B-6F87-494D-910F-40DF67B32318Q33405515-5373D689-225A-4E5C-BE4F-7D5E365CE47FQ33596386-1C6FC5B3-73E0-43F0-A81A-85431F5B445CQ33722475-61218E32-9B21-431D-B08A-83D726A3E997Q34798030-12A2A08F-42C8-4D5A-AC2F-C5EB85A48467Q35036494-F9FEB6C3-45EB-4066-835C-619F4E5D99B1Q35542385-68DD4EB3-3FD8-4A43-A22D-D16B8578A358Q35944738-66078B2C-3B70-4546-B679-7880C3EE0EA0Q36191026-5D0B0671-2D14-47E1-BD81-AB20B9E08534Q36602804-73B5D3A3-0352-4E78-B4DE-9AFE18CCD84AQ37419250-AB812A77-ECF5-42C6-8CFE-6D40B47179B5Q39207717-A541DFE9-D9EA-4E9B-8483-97945028FC95Q39422513-6F106489-1385-49EA-B25D-E68E8857AF1FQ40571167-3AFC3976-93F8-4DC9-BBE3-3A4D60812E97Q42776601-D0501969-AC6D-4BED-97FF-7D35B0E7730AQ45857806-B802260D-C043-4D9E-BD81-8D50ABA36086Q45861972-218B5C28-2834-4875-B269-E264E0B86C10Q47876814-23D6AD40-28B4-4360-B7ED-C6A77E2D85EBQ48516971-9C2E96B3-1E3E-4911-8B3E-BF600E04D5FBQ58416378-17055B50-5D4A-4D27-85E2-99B752E417B6
P2860
Acute renal failure resulting from intravenous immunoglobulin therapy.
description
1993 nî lūn-bûn
@nan
1993 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Acute renal failure resulting from intravenous immunoglobulin therapy.
@ast
Acute renal failure resulting from intravenous immunoglobulin therapy.
@en
type
label
Acute renal failure resulting from intravenous immunoglobulin therapy.
@ast
Acute renal failure resulting from intravenous immunoglobulin therapy.
@en
prefLabel
Acute renal failure resulting from intravenous immunoglobulin therapy.
@ast
Acute renal failure resulting from intravenous immunoglobulin therapy.
@en
P2093
P1433
P1476
Acute renal failure resulting from intravenous immunoglobulin therapy.
@en
P2093
P304
P356
10.1001/ARCHNEUR.1993.00540020015010
P577
1993-02-01T00:00:00Z